SHE:002332

2 stories mentioning SHE:002332Updated 42d ago

Every FINWIRES story that references SHE:002332, newest first.

Xianju Pharmaceutical Passes Generic Drug Review for Progesterone Injection Specification

Zhejiang Xianju Pharmaceutical (SHE:002332) said the 1ml:50mg specification for progesterone injection passed China's generic drug consistency evaluation.The injection is indicated for menstrual disorders, luteal deficiency, threatened and habitual abortion, premenstrual tension syndrome, and assisted reproductive therapy, according to a Wednesday filing with the Shenzhen bourse.The pharmaceutical company already holds approvals for 1ml:10mg and 1ml:20mg specifications.Shares of Zhejiang Xianju Pharmaceutical were down 2% Wednesday.

SHE:002332

Asia51d ago

Zhejiang Xianju Pharmaceutical Gets China Registration Nod for Vertigo Tablets

China's drug regulator approved Zhejiang Xianju Pharmaceutical's (SHE:002332) registration of its betahistine mesylate tablets, according to a Saturday filing with the Shenzhen Stock Exchange.The tablets are indicated for vertigo associated with Meniere's disease, the filing said.

SHE:002332

Track with the FINWIRES app suite

FolioX

Track SHE:002332 in your portfolio

WheelAI

Analyze SHE:002332 options with the wheel strategy

StockInsider

See market sentiment on SHE:002332